Table 2. Patient collective.
Characteristic | Number of patients (%) | |
Gender | ||
Male | 159 (78.7%) | |
Female | 43 (21.3%) | |
T-Stage | ||
T1 | 35 (17.3%) | |
T2 | 66 (32.7%) | |
T3 | 97 (48%) | |
T4 | 4 (2%) | |
N-Stage | ||
N0 | 75 (37.1%) | |
N1 | 127 (62.9%) | |
M-Stage | ||
M0 | 147 (86.1%) | |
M1 | 28 (13.9%) | |
Grading | ||
G1 | 4 (2%) | |
G2 | 122 (60.4%) | |
G3 | 76 (37.6%) | |
Cell Type | ||
Squamous cell carcinoma | 111 (55%) | |
Adenocarcinoma | 86 (42.6%) | |
Adenoaquamous carcinoma | 5 (2.5%) |
Characteristic of 202 patients that were evaluated for CXCR4 and HER2 expression.